Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025)
Neurocrine Biosciences (NBIX) posted Work In Process of $13.8 million for Q1 2025, up 26.61% on a QoQ basis from $10.9 million in Q4 2024, and up 15.0% year-over-year from $12.0 million in Q1 2024.
Neurocrine Biosciences (NBIX) Work In Process (2017 - 2025) Analysis & Trends
Neurocrine Biosciences' Work In Process history runs 9 years deep, the most recent figure standing at $13.8 million for Q1 2025.
- Quarterly Work In Process rose 15.0% year-over-year to $13.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $13.8 million (up 15.0% YoY) and the FY2024 annual result came in at $10.9 million, up 12.37% from the prior year.
- Work In Process was $13.8 million for Q1 2025 at Neurocrine Biosciences, up from $10.9 million in the prior quarter.
- Across five years, Work In Process topped out at $13.8 million in Q1 2025 and bottomed at $3.6 million in Q4 2021.
- A 5-year average of $9.8 million and a median of $10.8 million in 2024 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process soared 73.21% — and 2024, when it gained 12.37%.
- Neurocrine Biosciences' Work In Process stood at $3.6 million in 2021, then jumped by 55.56% to $5.6 million in 2022, then soared by 73.21% to $9.7 million in 2023, then climbed by 12.37% to $10.9 million in 2024, then climbed by 26.61% to $13.8 million in 2025.
- Business Quant data shows NBIX's Work In Process at $13.8 million in Q1 2025, $10.9 million in Q4 2024, and $10.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 13.80 Mn |
| Dec 31, 2024 | 10.90 Mn |
| Sep 30, 2024 | 10.60 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Dec 31, 2021 | 3.60 Mn |
| Dec 31, 2020 | 2.40 Mn |
| Mar 31, 2020 | 1.10 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 2.25 Mn |
| Jun 30, 2019 | 3.45 Mn |
| Mar 31, 2019 | 4.46 Mn |
| Dec 31, 2018 | 2.21 Mn |
| Sep 30, 2018 | 270,000.00 |
| Dec 31, 2017 | 491,000.00 |